InvestorsHub Logo
Followers 51
Posts 3073
Boards Moderated 1
Alias Born 06/28/2017

Re: None

Tuesday, 05/14/2019 8:58:14 AM

Tuesday, May 14, 2019 8:58:14 AM

Post# of 9239
$CRON get NICE mention in new report on the FDA CBD Trials

http://fortunenewswire.com/aurora-cannabis-acb-and-others-receive-price-upgrades-following-cbd-trial-update-research-results/

Top Cannabis companies such as Aphria (NYSE:APHA), Cronos Group (NASDAQ:CRON), Canopy Growth (NYSE:CGC) and Aurora Cannabis (NYSE:ACB) are among the most anticipated cannabis stocks to monitor during these trials, which is set to take place in April to look into how the FDA might legalize CBD-additives in food products. These four cannabis giants stand to benefit significantly from a positive out-come of the trails, which ultimately aim to loosen the constraints of adding cannabis related products to food and drinks.


Come on baby, lets break out!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRON News